Home / Pharmaceuticals / In-Vitro Diagnostics (IVD) Market By Products (Reagents, Instruments, Software And Services), By Techniques (Clinical Chemistry, Immunochemistry/Immunoassays, Hematology, Coagulation And Hemostasis, Microbiology, Molecular Diagnostics (MDX)), By Test Locations (Point-Of-Care Testing, Central Lab Testing, OTC/Self Testing) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

In-Vitro Diagnostics (IVD) Market By Products (Reagents, Instruments, Software And Services), By Techniques (Clinical Chemistry, Immunochemistry/Immunoassays, Hematology, Coagulation And Hemostasis, Microbiology, Molecular Diagnostics (MDX)), By Test Locations (Point-Of-Care Testing, Central Lab Testing, OTC/Self Testing) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: May 2016 | Report Code: 57810-05-16

The global in-vitro diagnostics (IVD) market has considerably evolved over the past decade with the introduction of innovative diagnosis options. Major factors contributing to the growth of in-vitro diagnostics market include growing incidence of chronic diseases, aging population and growing demand for point-of-care testing. Advancements in the field of genomics and proteomics, introduction of condition-specific markers and development of healthcare infrastructure in emerging economies create future prospects for the market.

This report studies the global in-vitro diagnostics market on the basis of four major segmentations: products, techniques, test locations and geography. Reagents, instruments, and software and services together make the IVD market by products. Clinical chemistry,  immunochemistry/immunoassays, hematology, coagulation and hemostasis, microbiology, molecular diagnostics (MDX) and others are the IVD techniques studied in the report. Based on test locations, IVD is practiced across point-of-care testing, central lab testing and OTC/self testing. Each of the mentioned segments is analyzed for their market size and forecast and major trends observed in each category. The market size and forecast is provided for the period 2014-2022 with the individual compounded annual growth rates (CAGR %) for the period 2016-2022 while considering 2015 as the base year.

Based on geographical distribution, the global in-vitro diagnostics market is studied for North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America regional markets. Analysis for key country level markets for major regional markets are also provided in this study. Market size and forecast for each regional and country level markets is provided in this report for the period 2014-2022 along with their respective CAGRs during 2016-2022, considering 2015 as the base year.

This distribution is elucidated as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

Along with the quantitative data, qualitative information sets such as market dynamics and executive summary for the global in-vitro diagnostics market are included in the report. Fractal map analysis and attractive investment proposition tools are also included in the report or competition assessment. This study concludes with company profiles section, which includes major information about the key companies engaged in development, manufacture and sale of IVD technologies.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
2.2 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
2.3 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
2.4 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)

Chapter 3 In-vitro Diagnostics Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global In-vitro Diagnostics Market Analysis, by Products
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services

Chapter 5 Global In-vitro Diagnostics Market Analysis, by Techniques
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others

Chapter 6 Global In-vitro Diagnostics Market Analysis, by Test Locations
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing

Chapter 7 Global In-vitro Diagnostics Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bayer AG.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Becton, Dickson and Company
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 bioMérieux
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/Portfolio
8.4.4 News Coverage
8.5 Bio-Rad Laboratories, Inc.
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 News Coverage
8.6 Danaher Corporation
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 News Coverage
8.7 Johnson & Johnson Pvt Ltd.
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 News Coverage
8.8 Roche Diagnostics
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 News Coverage
8.9 Siemens AG
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 News Coverage
8.10 Sysmex Corporation
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 News Coverage
8.11 Others
8.11.1 Business Description
8.11.2 Financial Health and Budget Allocation
8.11.3 Product Positions/Portfolio
8.11.4 News Coverage

List Of Table :

TABLE 1 Global In-vitro Diagnostics Market, by Products, 2014 – 2022 (USD Mn)
TABLE 2 Global In-vitro Diagnostics Market, by Techniques, 2014 – 2022 (USD Mn)
TABLE 3 Global In-vitro Diagnostics Market, by Test Locations, 2014 – 2022 (USD Mn)
TABLE 4 Global In-vitro Diagnostics Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 5 North America In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 6 Europe In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 7 Asia-Pacific In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)

List Of Figure : 

FIG. 1 In-vitro Diagnostics: Market Segmentation
FIG. 2 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
FIG. 3 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
FIG. 4 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
FIG. 5 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)
FIG. 6 Attractive Investment Proposition, In-vitro Diagnostics Market, 2015
FIG. 7 Competitive Analysis: Fractal Map Investigation, by Key Market Players
FIG. 8 Global IVD Reagents Market, 2014 – 2022 (USD Mn)
FIG. 9 Global IVD instruments Market, 2014 – 2022 (USD Mn)
FIG. 10 Global IVD Software and Services Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Clinical Chemistry IVD Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Immunochemistry/Immunoassays IVD Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Hematology IVD Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Coagulation and Hemostasis IVD Market, 2014 – 2022 (USD Mn)
FIG. 15 Global Microbiology IVD Market, 2014 – 2022 (USD Mn)
FIG. 16 Global Molecular Diagnostics (MDX) IVD Market, 2014 – 2022 (USD Mn)
FIG. 17 Global Other IVD Techniques IVD Market, 2014 – 2022 (USD Mn)
FIG. 18 Global IVD in Point-of-Care Testing Market, 2014 – 2022 (USD Mn)
FIG. 19 Global IVD in Central Lab Testing Market, 2014 – 2022 (USD Mn)
FIG. 20 Global IVD in OTC/Self Testing Market, 2014 – 2022 (USD Mn)
FIG. 21 U.S. In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 22 Canada In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 23 U.K. In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 24 Germany In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 25 Rest of Europe In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 26 Japan In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 27 China In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 28 Rest of Asia-Pacific In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 29 Middle East and Africa In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 30 Latin America In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)

The global in-vitro diagnostics market is studied for the following product types:

  • Reagents
  • Instruments
  • Software and Services

In-Vitro Diagnostics (IVD) Market

The in-vitro diagnostics market is dominated by reagents segment both in terms of market revenue and market growth rate. The dominance of this segment is largely attributed to the large scale consumption of these products across all the techniques and applications. Easy access to a wide range of reagents based on specificity of needs, and their reliability in detection of chronic diseases also plays a vital role in determining the growth of this segment.

Test Locations Segmentation Investigation

Point-of-care testing, central lab testing and OTC/self testing are the locations where IVD is applied.

In-Vitro Diagnostics (IVD) Market

A great majority of in-vitro testing is still performed in central laboratories such as those of hospitals, path labs, blood banks etc. However, as of the recent trends, IVD tests are also being increasingly performed in point-of-care locations such as clinics, physician offices and others. Over-the-counter or self testing represents over 10% share of the overall in-vitro diagnostics market. Consistent innovation and thereby the resultant growth in OTC product offering plays a vital role in the growth of this segment.

Based on the techniques global in-vitro diagnostics market is segmented into:

  • Clinical Chemistry
  • Immunochemistry/Immunoassays
  • Hematology
  • Coagulation and Hemostasis
  • Microbiology
  • Molecular Diagnostics (MDX)
  • Others

In-Vitro Diagnostics (IVD) Market

Clinical chemistry segment dominates the IVD market across all the major regional and national markets. Molecular diagnostics market is estimated to take over dominance in the global market during the forecast period during the forecast period. Molecular diagnostic tools drive the perpetual discovery of biomarkers and thus in innovation of various treatments for chronic diseases and also personalized medicine. Innovation in the field of molecular diagnostics has also given rise to companion diagnostics for identification of specific therapies.

Geographically, the in-vitro diagnostics market is cumulative to North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

The detailed regional classification of this market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany and Rest of Europe)
  • Asia-Pacific (Japan, China and Rest of Asia-Pacific)
  • Middle East and Africa
  • Latin America

In-Vitro Diagnostics (IVD) Market

North America is the largest regional segment in the global in-vitro diagnostics market, followed by Europe. High prevalence of chronic diseases, well-defined healthcare policies, rapid adoption of advanced technologies and positive adoption of novel molecular diagnostic technologies and point-of-care testing play a critical role in the dominance of these regions on the global front. Additionally, increasing government initiatives, growth in clinical research activities and growing healthcare expenditure in Asia-Pacific and Latin America together drive the significant growth in these markets.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients